Medscape June 20, 2024
Kathleen Doheny

“My weight has always been kind of an issue,” said Gerald Fernandez, a 33-year-old mortgage broker in Naples, Florida. Over the years, he has sought advice from his physicians but felt unsatisfied with the guidance he has received: “They never gave me a solution, besides ‘Work out more, eat less.'”

Earlier this year, Fernandez found a new clinician who suggested he take a glucagon-like peptide 1 (GLP-1) receptor agonist for weight loss. He said he has lost about 20 lb in the 3 months he has been taking compounded semaglutide. But the medication is not the only difference-maker this time.

When Fernandez’s doctor, Yanet Diaz-Martell, MD, an internist and hospitalist at Physicians Regional Healthcare System in Naples, Florida, discussed his...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Physician, Provider
Seattle biotech startup Bonum upgrades offices, expands team in its pursuit of cancer drugs
Pfizer, Valneva inch closer to FDA approval of 1st Lyme disease vaccine
New Gene Therapy for Muscular Dystrophy May Facilitate Development of Others
Weight Loss Drugs’ Effects Could Be Improved by Priming Melanocortin System
J&J IRA pricing offer is in, as it sticks with 2025 guidance

Share This Article